Eli Lilly (LLY): FY24 Q4 earnings call, Feb 6, 2025
No Kalshi or Polymarket word markets were listed for Eli Lilly’s Feb 6, 2025 earnings call (FY24 Q4). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
4 matches for “LillyDirect”; 4 quoted, at least 25 words apart.
…'24 compared to the second half of '23. With more patients using Lilly Direct, the uptake of single-use Zepbound vials increased. We had no wholesaler…
Yes. We launched the self-pay system with Lilly Direct back in late August, and we are pleased with the performance so far. In terms of…
…purchase FDA-approved authentic medicines. And it's really about connecting that software to Lilly Direct self-pay pharmacy. And we will lean into additional partnerships along those…
…of "new product" launch cadence with patient assistance programs and the implementation of channel tools like Lilly Direct, should all those be at the outset?
Agents: this page as TSV at /api/v1/appearances/eli-lilly:2025-02-06:earnings_call · words: /api/v1/brief?appearance=eli-lilly:2025-02-06:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP